Barale C, Buracco S, Cavalot F, Frascaroli C, Guerrasio A, Russo I: Glucagon-like peptide 1-related peptides increase nitric oxide effects to reduce platelet activation
To ensure that findings are generalizable, key next steps will be to replicate and extend this work with variations of the target (e.g., gender, race/ethnicity, prior attempts at weight loss, cost paid for medication) and diverse groups of participants, both in terms of participant demographics and preexisting knowledge of GLP-1s (e.g., general population, eligible patients, healthcare professionals)
Common experiences: Fewer cravings Lighter, more predictable hunger Mild nausea if eating too fast or too much What your medical weight loss plan includes: Provider check-in or messaging support Personalized nutrition feedback Maintaining daily movement Reinforcing protein-first eating, which is vital for protecting muscle mass Week 2 priority: Dialing in slow eating, small portions, hydration, and balanced meals
Temporary shedding